Trends in Fluoroquinolone (Ciprofloxacin) Resistance inEnterobacteriaceaefrom Bacteremias, England and Wales, 1990–1999
Open Access
- 1 May 2002
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (5) , 473-478
- https://doi.org/10.3201/eid0805.010204
Abstract
The Public Health Laboratory Service receives antibiotic susceptibility data for bacteria from bloodstream infections from most hospitals in England and Wales. These data were used to ascertain resistance trends to ciprofloxacin from 1990 through 1999 for the most prevalent gram-negative agents: Escherichia coli, Klebsiella spp., Enterobacter spp., and Proteus mirabilis. Significant increases in resistance were observed for all four species groups. For E. coli, ciprofloxacin resistance rose from 0.8% in 1990 to 3.7% in 1999 and became widely scattered among reporting hospitals. The prevalence of resistance in Klebsiella spp. rose from 3.5% in 1990, to 9.5% in 1996 and 7.1% in 1999, while that in Enterobacter spp. rose from 2.1% in 1990 to 10.5% in 1996 and 10.9% in 1999. For both Klebsiella and Enterobacter spp., most resistance was localized in a few centers. Resistance was infrequent and scattered in P. mirabilis, but reached a prevalence of 3.3% in 1999.Keywords
This publication has 21 references indexed in Scilit:
- Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991–1997, as assessed by routine and centralized testingJournal of Antimicrobial Chemotherapy, 2000
- Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysisBMJ, 2000
- Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial LevofloxacinJournal of Medicinal Chemistry, 1999
- Quinolone resistance from a transferable plasmidPublished by Elsevier ,1998
- Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: a 6-year study of isolates from patients in England and WalesInternational Journal of Antimicrobial Agents, 1998
- Molecular Epidemiological Analysis of Quinolone‐ResistantEscherichia coliCausing Bacteremia in Neutropenic Patients with Leukemia in KoreaClinical Infectious Diseases, 1997
- Emergence of fluoroquinolone-resistant Escherichia coli at a cancer centerAntimicrobial Agents and Chemotherapy, 1994
- Use of the Quinolones for the Prophylaxis and Therapy of Infections in Immunocompromised HostsDrugs, 1993
- Amantadine prophylaxis for health care workers: unanswered questionsJournal of Antimicrobial Chemotherapy, 1991
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983